Abstract
Phase 1b Study of Carfilzomib in Combination with Induction Chemotherapy in Children with Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have